Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease

(MedPage Today) — Adding ivonescimab to chemotherapy prolonged progression-free survival (PFS) in previously treated advanced EGFR-mutant non-small cell lung cancer (NSCLC), but failed to significantly improve overall survival (OS), the phase…

Source link : https://www.medpagetoday.com/meetingcoverage/iaslc/117380

Author :

Publish date : 2025-09-09 19:22:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

Ivonescimab Delays Lung Cancer Progression in EGFR-Mutated Disease

‘Great Migration’ involves far fewer wildebeest than we had thought

CDC Autism Data Reviewed; Gabapentin Prescribing Concerns; Smoking and Parkinson’s

Related Posts

Stem cell therapy lowers risk of heart failure after a heart attack

Adding Physical Therapy Did Not Further Reduce Knee Pain From Meniscal Tear

PSA Screening Reduces Prostate Cancer Deaths, Long-Term Data Show

NHS Opt-Out Tests Identify Undiagnosed Infections

FDA Launches Effort to Ease Approval Pathway for Biosimilars

New Valves Treat ‘No-Option’ Heart Patients

Stem cell therapy lowers risk of heart failure after a heart attack

Adding Physical Therapy Did Not Further Reduce Knee Pain From Meniscal Tear

PSA Screening Reduces Prostate Cancer Deaths, Long-Term Data Show

NHS Opt-Out Tests Identify Undiagnosed Infections

FDA Launches Effort to Ease Approval Pathway for Biosimilars

New Valves Treat ‘No-Option’ Heart Patients

A tiny nearby galaxy is home to a shockingly enormous black hole

A Cooler Pancreas? Device Shows Promise in Early-Stage Trial

Categories

Archives